Medication info
Tenelipone Sustained Release Tablet 10/500 mg

Tenelipone Sustained Release Tablet 10/500 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Daehan New Pharm Co., Ltd.
Appearance
Orange egg-shaped sustained release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201319 · Approved 2022.04.04 · Insurance code 669908190

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse effects associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be monitored closely and the dose adjusted appropriately. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another antihyperglycemic agent. Since such a change may cause changes in blood glucose control, any change in treatment for patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
Daehan New Pharm Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes

View approved original text

This medicine is used alongside diet and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. The two ingredients, teneligliptin and metformin, work together to effectively lower and improve blood sugar levels. Therefore, taking this medicine greatly contributes to stabilizing diabetes symptoms by maintaining good blood sugar control.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse effects associated with metformin. Take one 20/1000mg extended-release tablet once daily. Patients taking the 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients whose blood glucose is not adequately controlled with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be initiated at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, blood glucose control should be monitored closely and the dose adjusted appropriately. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another antihyperglycemic agent. Since such a change may cause changes in blood glucose control, any change in treatment for patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medicine can rarely cause a serious condition called lactic acidosis. Lactic acidosis is a dangerous condition caused by excessive accumulation of lactic acid in the body, which can be life-threatening if not treated. During the use of this medicine, hypoglycemia may occur, so extra caution is needed, especially when taken with insulin or sulfonylurea drugs. If symptoms of hypoglycemia appear, it is important to immediately consume food that contains sugar. This medicine is not to be administered to patients whose renal function is moderately impaired or worse, or who have serious conditions such as heart failure, acute myocardial infarction, or sepsis. Additionally, if iodine-based contrast agents used in radiological examinations are administered, this medicine should be discontinued 48 hours prior to the examination and resumed only after confirming normal kidney function. It is also unsafe for women who are pregnant or may become pregnant, patients with liver dysfunction, patients with severe infections or traumatic conditions, and patients with very poor nutritional status to use this medicine. Due to the risk of hypoglycemia, patients with irregular meal patterns or insufficient meal quantities, those who engage in vigorous exercise, or those taking sulfonylurea or insulin should be particularly cautious. Regular checks of liver and kidney functions should be performed during the use of this medicine, and if any unusual symptoms such as gastrointestinal disturbances, liver dysfunction, acute pancreatitis, or skin rashes appear, one should immediately consult a physician. Alcohol consumption may increase the risk of lactic acidosis, so it is advisable to avoid drinking while taking this medicine. Elderly patients are more prone to renal function decline, thus dosage adjustment and regular monitoring of renal function is necessary. If breastfeeding, the use of this medicine is not recommended, and one should consult a doctor whether to continue breastfeeding or discontinue medication. In case of overdose, one should immediately visit a medical institution for appropriate treatment, and the drug can be removed through hemodialysis. This medicine should be stored out of reach of children and should not be transferred to another container. During the use of this medicine, one should be well aware of the symptoms of hypoglycemia and lactic acidosis, and in case of any suspected symptoms, immediately inform healthcare providers.

Side effects

Severe lactic acidosis, severe hypoglycemia, hypoglycemia, constipation, intestinal obstruction, liver dysfunction, interstitial pneumonia, similar to dermatitis herpetiformis, acute pancreatitis, dizziness, abdominal distension, abdominal discomfort, nausea, abdominal pain, bloating, stomatitis, gastric polyp, colon polyp, duodenal ulcer, gastroesophageal reflux disease, diarrhea, decreased appetite, elevated amylase, elevated lipase, elevated AST (GOT), elevated ALT (GPT), elevated GGT, elevated ALP, proteinuria, ketonuria, potential hematuria, eczema, rash, itching, allergic dermatitis, arthralgia, elevated CK (CPK), increased serum potassium concentration, malaise, allergic rhinitis, elevated serum uric acid, peripheral edema, herpes zoster, limb pain, upper abdominal pain, gastritis, upper respiratory infection, tremors, headache, asthenia, hunger, fatigue, facial edema, dyspepsia, nausea, viral upper respiratory infection, rhinitis, cold sweats, diabetic retinopathy, decreased vision, cough, pulmonary congestion, dyspnea, drug overdose, benign prostatic hyperplasia, headache, diarrhea, chronic gastritis, irritable bowel syndrome, fatigue, cerebral infarction, hyperglycemia, liver biopsy, decreased neutrophils, blood glucose abnormality, increased blood glucose, increased blood pressure, hepatic coma, lumbar spinal canal stenosis, intervertebral disc herniation, intervertebral disc disorder, spinal ligament ossification, foraminal stenosis, rotator cuff syndrome, bladder mass, ureteral calculus, urinary stones, coronary artery disease, unstable angina, gastroesophageal reflux disease, gastric polyps, gastritis, biliary obstruction, chronic cholecystitis, soft tissue infection, pneumonia, cataract, depression, iliac artery stenosis, vertigo, benign prostatic hyperplasia, knee surgery, dizziness, diabetic neuropathy, sensory abnormalities, muscular weakness, low back pain, limb pain, tendonitis, cervical pain, bone pain, osteoarthritis, osteoporosis, muscle cramps, foot deformity, hypertrophic osteoarthritis, bursitis, spinal osteoarthritis, postmenopausal osteoporosis, chronic gastritis, vomiting, abdominal pain, gastrointestinal motility disorder, decreased gastrointestinal motility, enteritis, toothache, anal rectal discomfort, acquired mixed hyperlipidemia, hypertriglyceridemia, vitamin D deficiency, abnormal weight gain, essential hypertension, orthostatic hypotension, white coat hypertension, bleeding, abnormal sputum, dyspnea, exertional dyspnea, atelectasis, epistaxis, chest discomfort, fever, chills, generalized edema, injection site inflammation, dysuria, renal cyst, nocturia, depression, anxiety disorder due to general medical conditions, ovarian cyst, vulvar pruritus, menopausal symptoms, toxic hepatitis, nonalcoholic fatty liver disease, alcoholic liver disease, eyelid damage, ligament sprain, lip injury, bruise, urticaria, glaucoma, blurred vision, age-related macular degeneration, hyperthyroidism, hyperparathyroidism, angina, otalgia, iron deficiency anemia, food allergies, pressure ulcer, hearing loss, endolymphatic hydrops

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly sealed container to prevent air from entering, and it is best to store it at room temperature between 1°C and 30°C. Storing it this way helps to maintain the efficacy of the medication for a longer time.

Appearance and packaging

Appearance

Orange egg-shaped sustained release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.